Functional role of MIA in melanocytes and early development of melanoma (Q28267890)

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

Functional role of melanoma inhibitory activity in regulating invasion and metastasis of malignant melanoma cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

Structure and promoter analysis of the gene encoding the human melanoma-inhibiting protein MIA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

Apoptosis regulators and responses in human melanocytic and keratinocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

Apaf-1 is a mediator of E2F-1-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

Melanoma development and progression: a conspiracy between tumor and host

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

MMP-2, TIMP-2 and MT1-MMP are differentially expressed in lesional skin of melanocytic nevi and their expression is modulated by UVB-light

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

Human melanoma cells derived from lymphatic metastases use integrin alpha v beta 3 to adhere to lymph node vitronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

Backbone dynamics of the human MIA protein studied by (15)N NMR relaxation: implications for extended interactions of SH3 domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

The plasminogen activation system in melanoma cell lines and in melanocytic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

7 January 2021

Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

7 January 2021

Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

7 January 2021

Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

7 January 2021

Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

7 January 2021

Plasminogen activators, activation inhibitors and alpha 2-macroglobulin produced by cultured normal and malignant human cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

7 January 2021

Sequence-specific 1H, 13C, and 15N assignment of the human melanoma inhibitory activity (MIA) protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207797

7 January 2021